Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 31
17
Diseases
61
Unique genes
0.247
Avg. similarity score
11p partial monosomy syndrome
Most-connected disease (8 links)
Disease
Searched: 11p partial monosomy syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
11p partial monosomy syndrome
Congenital aniridia
Denys drash syndrome
Drash syndrome
Desmoplastic small round cell tumor
Wagr syndrome
wilms tumor 1
Ambiguous genitalia
Peritoneal neoplasms
Aniridia
Wilms tumor
Angiomatoid fibrous histiocytoma
Ewing sarcoma
Ocular dysgenesis
Autoimmune nervous system disorder
Schaaf-yang syndrome
Shukla-vernon syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| 11p partial monosomy syndrome | 8 | 8 | 1 |
| Congenital aniridia | 8 | 8 | 2 |
| Denys drash syndrome | 8 | 8 | 1 |
| Drash syndrome | 8 | 8 | 1 |
| Desmoplastic small round cell tumor | 7 | 7 | 2 |
| Wagr syndrome | 7 | 7 | 4 |
| wilms tumor 1 | 7 | 7 | 1 |
| Ambiguous genitalia | 5 | 5 | 5 |
| Peritoneal neoplasms | 5 | 5 | 10 |
| Aniridia | 3 | 3 | 9 |
| Wilms tumor | 3 | 3 | 32 |
| Angiomatoid fibrous histiocytoma | 2 | 2 | 2 |
| Ewing sarcoma | 2 | 2 | 5 |
| Ocular dysgenesis | 2 | 2 | 1 |
| Autoimmune nervous system disorder | 1 | 1 | 4 |
| Schaaf-yang syndrome | 1 | 1 | 1 |
| Shukla-vernon syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| WT1 | 11 / 17 | 11p partial monosomy syndrome, Ambiguous genitalia, Aniridia, Congenital aniridia and 7 more |
| PAX6 | 4 / 17 | Aniridia, Congenital aniridia, Wagr syndrome, Wilms tumor |
| ELP4 | 3 / 17 | Aniridia, Ocular dysgenesis, Wagr syndrome |
| EWSR1 | 3 / 17 | Angiomatoid fibrous histiocytoma, Desmoplastic small round cell tumor, Ewing sarcoma |
| BCORL1 | 2 / 17 | Shukla-vernon syndrome, Wilms tumor |
| CTNNB1 | 2 / 17 | Peritoneal neoplasms, Wilms tumor |
| MAGEL2 | 2 / 17 | Ambiguous genitalia, Schaaf-yang syndrome |
| MCAM | 2 / 17 | Autoimmune nervous system disorder, Peritoneal neoplasms |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| MicroRNA (miRNA) biogenesis | Reactome | 4 / 24 | 32.8× | 5.93e-6 | 2.11e-4 ✓ sig. |
| Transcriptional misregulation in cancer | KEGG | 7 / 198 | 7.0× | 6.11e-5 | 1.46e-3 ✓ sig. |
| Proteoglycans in cancer | KEGG | 6 / 204 | 5.8× | 5.69e-4 | 8.71e-3 ✓ sig. |
| NGF-stimulated transcription | Reactome | 3 / 35 | 16.9× | 7.27e-4 | 1.05e-2 ✓ sig. |
| MAPK signaling pathway | KEGG | 7 / 299 | 4.6× | 7.62e-4 | 1.09e-2 ✓ sig. |
| Polycomb repressive complex | KEGG | 4 / 83 | 9.5× | 8.20e-4 | 1.15e-2 ✓ sig. |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | Reactome | 2 / 13 | 30.3× | 1.91e-3 | 2.21e-2 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 4 / 108 | 7.3× | 2.18e-3 | 2.42e-2 ✓ sig. |
| Defective EXT2 causes exostoses 2 | Reactome | 2 / 14 | 28.1× | 2.22e-3 | 2.46e-2 ✓ sig. |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | Reactome | 2 / 14 | 28.1× | 2.22e-3 | 2.46e-2 ✓ sig. |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Reactome | 2 / 14 | 28.1× | 2.22e-3 | 2.46e-2 ✓ sig. |
| Misspliced GSK3beta mutants stabilize beta-catenin | Reactome | 2 / 15 | 26.3× | 2.55e-3 | 2.73e-2 ✓ sig. |
| S33 mutants of beta-catenin aren't phosphorylated | Reactome | 2 / 15 | 26.3× | 2.55e-3 | 2.73e-2 ✓ sig. |
| S37 mutants of beta-catenin aren't phosphorylated | Reactome | 2 / 15 | 26.3× | 2.55e-3 | 2.73e-2 ✓ sig. |
| S45 mutants of beta-catenin aren't phosphorylated | Reactome | 2 / 15 | 26.3× | 2.55e-3 | 2.73e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of DNA-templated transcription | GO:0045893 | 20 / 778 | 7.9× | 2.40e-13 | 1.23e-10 ✓ sig. |
| anatomical structure morphogenesis | GO:0009653 | 10 / 160 | 19.1× | 9.89e-11 | 2.91e-8 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 19 / 1,002 | 5.8× | 2.11e-10 | 5.75e-8 ✓ sig. |
| regulation of DNA-templated transcription | GO:0006355 | 22 / 1,454 | 4.6× | 3.94e-10 | 9.87e-8 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 19 / 1,208 | 4.8× | 4.78e-9 | 8.82e-7 ✓ sig. |
| kidney development | GO:0001822 | 8 / 146 | 16.8× | 2.38e-8 | 3.58e-6 ✓ sig. |
| epithelial cell differentiation | GO:0030855 | 7 / 110 | 19.5× | 6.78e-8 | 8.62e-6 ✓ sig. |
| regulation of gene expression | GO:0010468 | 10 / 402 | 7.6× | 6.44e-7 | 5.77e-5 ✓ sig. |
| negative regulation of apoptotic process | GO:0043066 | 11 / 524 | 6.4× | 8.92e-7 | 7.53e-5 ✓ sig. |
| pituitary gland development | GO:0021983 | 4 / 30 | 40.8× | 2.64e-6 | 1.81e-4 ✓ sig. |
| miRNA metabolic process | GO:0010586 | 3 / 12 | 76.6× | 7.13e-6 | 4.03e-4 ✓ sig. |
| regulation of transcription by RNA polymerase II | GO:0006357 | 17 / 1,602 | 3.3× | 9.36e-6 | 5.01e-4 ✓ sig. |
| mesenchymal cell differentiation involved in kidney development | GO:0072161 | 2 / 2 | 306× | 1.05e-5 | 5.45e-4 ✓ sig. |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 4 / 45 | 27.2× | 1.39e-5 | 6.79e-4 ✓ sig. |
| in utero embryonic development | GO:0001701 | 7 / 252 | 8.5× | 1.75e-5 | 8.12e-4 ✓ sig. |